Skip to main content
AIM Vaccine Co., Ltd. logo

AIM Vaccine Co., Ltd. — Investor Relations & Filings

Ticker · 6660 ISIN · CNE100005KF2 HKEX Manufacturing
Open in API
Filings indexed 238 across all filing types
Latest filing 2026-06-10 Declaration of Voting R…
Country HK Hong Kong
Listing HKEX 6660

About AIM Vaccine Co., Ltd.

https://www.aimbio.com

AIM Vaccine Co., Ltd. is a biopharmaceutical company focused on the research, development, manufacturing, and commercialization of vaccines for human use. The company's mission is to produce high-quality vaccines to safeguard global health. It holds a leading position among privately-owned vaccine enterprises in its primary market. The core product portfolio includes established vaccines such as Recombinant Hepatitis B Vaccine (Hansenula polymorpha), Inactivated Hepatitis A Vaccine (Human Diploid Cell), and Meningococcal Polysaccharide Vaccine. AIM Vaccine is also a major global supplier of rabies vaccines, committed to leading technological advancements in this area. The company actively expands its pipeline, which features advanced candidates like the 13-valent pneumonia conjugate vaccine and iterative serum-free rabies vaccine, alongside strategic investments in mRNA technology, including an mRNA COVID-19 vaccine candidate.

Recent filings

Filing Released Lang Actions
(1) POLL RESULTS OF THE 2026 FIRST EXTRAORDINARY GENERAL MEETING HELD ON JUNE 10, 2026; AND (2) AMENDMENTS TO THE ARTICLES OF ASSOCIATION
Declaration of Voting Results & Voting Rights Announcements Classification · 94% confidence The document is an official announcement of the poll results of the 2026 first Extraordinary General Meeting (EGM), showing vote counts for special and ordinary resolutions and confirming which resolutions were passed, along with amendments to the articles of association. This matches the definition of a Declaration of Voting Results & Voting Rights Announcement.
2026-06-10 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information Classification · 85% confidence The document is a list of the company’s board members and committee memberships, detailing the composition of the Board and its committees. This is not a full report or presentation but clearly internal board/management information concerning director roles and functions. It fits the “Board/Management Information” category.
2026-06-10 English
Articles of Association
Governance Information Classification · 90% confidence The document is the Articles of Association of AIM Vaccine Co., Ltd., containing the company’s internal rules on share issuance, board structure, shareholder meetings, and governance provisions. This aligns with the Governance Information category (CGR).
2026-06-10 English
(1) POLL RESULTS OF THE 2025 ANNUAL GENERAL MEETING HELD ON JUNE 10, 2026; (2) AMENDMENTS TO THE ARTICLES OF ASSOCIATION; (3) RESIGNATION OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND APPOINTMENT OF DIREC
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Hong Kong stock exchange announcement detailing the poll results of the 2025 Annual General Meeting held on June 10, 2026, along with related items such as amendments to the articles of association, resignation and appointment of directors, and changes in board committees. This is a direct publication of voting outcomes at the AGM rather than the AGM materials themselves or a summary report. It therefore falls squarely under ‘Declaration of Voting Results & Voting Rights Announcements’ (DVA).
2026-06-10 English
SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2025
Earnings Release Classification · 85% confidence The document is a “Supplemental Announcement” providing additional detail on impairment losses and financial adjustments related to the Company’s annual results for the year ended December 31, 2025. It is not a full annual report (10-K) or interim/quarterly report (IR), nor is it a formal audit report or other regulatory/compliance filing. Instead, it supplements the initial annual results announcement – which in our taxonomy falls under Earnings Release (ER). The content contains substantive financial amounts and adjustments, aligning it with an earnings release rather than a mere publication announcement or certification. Therefore, the appropriate classification is ER. FY 2025
2026-06-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2026
Regulatory Filings Classification · 85% confidence The document is a HKEX “Monthly Return” submission (Form FF301) detailing share capital movements and confirmations under the Exchange Listing Rules for the month ended 31 May 2026. It is a periodic regulatory compliance return rather than an annual or interim report, earnings release, or specific share issuance announcement. It falls under general regulatory filings for compliance with listing rules.
2026-06-03 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.